Theravance Biopharma, Inc. Stock Issued During Period, Shares, New Issues
Theravance Biopharma, Inc. (TBPH) had Stock Issued During Period, Shares, New Issues of 7.71 million shares as of 2021-06-29, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2023-03-01
- 2021-06-29: Stock Issued During Period, Shares, New Issues 7.71M shares.
- 2020-02-14: Stock Issued During Period, Shares, New Issues 5.50M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2021-06-29 | 7.71M shares 10-K · filed 2023-03-01 |
| 2020-02-14 | 5.50M shares 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |